3D conformal HDR-brachy- and external beam therapy plus simultaneous Cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up

Radiotherapy and Oncology

Volumn 79, Issue 1, 2006, Pages 80-86

  Pötter, Richard ^a   Dimopoulos, Johannes ^a   Bachtiary, Barbara ^a   Sissolak, Gerhard ^a,b   Klos, Beata ^a   Rheinthaller, A ^c   Kirisits, C ^a   Knocke Abulesz, Tomas Hendrik ^a,d  

^a Department of Radiotherapy and Radiobiology ^*  (Austria)

^b Clinical Division of Oncology   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Hospital of Lainz   (Austria)

Author keywords

3D HDR brachytherapy; Cervical cancer; Cisplatin; Radiochemotherapy

Indexed keywords

BENZYDAMINE; CISPLATIN; ESTRIOL; OMEPRAZOLE; RECOMBINANT ERYTHROPOIETIN; TROPISETRON;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BLADDER DISEASE; BLOOD TRANSFUSION; BODY SURFACE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYDRONEPHROSIS; KIDNEY FAILURE; LEUKOPENIA; LUNG EMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; THREE DIMENSIONAL IMAGING; THROMBOCYTOPENIA; TREATMENT RESPONSE; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; VAGINA DISEASE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 33646188096     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.01.007     Document Type: Article

References (24)

1. Chen S.W., Liang J.A., Yang S.N., Ko H.L., and Lin F.J. The adverse effect of treatment prolongation in cervical cancer by high-dose rate intracavitary brachytherapy. Radiother Oncol 67 (2003) 69-76
2. Clark B.G., Souhami L., Roman T.N., Evans M.D.C., and Pla C. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irridation with high dose rate brachytherapy: a dosimetric analyis. Int J Radiat Oncol Biol Phys 28 (1994) 1243-1250
3. Clark B.G., Souhami L., Roman T.N., Chappell R., Evans M.D.C., and Fowler J.F. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 38 (1997) 989-993
4. Common Toxicity Criteria Manual, Version 2.0. Bethesda, MD: Division of Cancer Treatment, National Cancer Institute; June 1, 1999.
5. Davidson S., Burns M.P., Routledge J.A., Swindel R., Bentzen S.M., and West C.M.L. Assessment of morbidity in carcinoma of the cervix: a comparisonof the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 69 (2003) 195-200
6. Dimopoulos J, Lang S, Kirisits C, et al. Combined MRI-based intracavitary and interstitial brachytherapy for locally advanced cervical cancer with a modified tandem ring applicator-clinical feasibility and preliminary results. Radiother Oncol 2004; 77 (Suppl.2):S10.
7. Fyles A., Keane T.J., Barton M., and Simm J. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 35 (1995) 107-117
8. Gerstner N., Wachter S., Knocke Th., Fellner C., Wambersie A., and Pötter R. The benefit of Beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol 51 (1999) 71-78
9. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
10. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
11. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
12. Kirisits C., Potter R., Lang S., Dimopoulos J., Wachter-Gerstner N., and Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
13. LENT SOMA tables. Radiother Oncol 1995;39:191.
14. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
15. Obermair A., Cheuk R., Horwood K., et al. Impact of haemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 92 (2001) 903-908
16. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
17. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
18. Pötter R., Knocke T.H., Fellner C., Baldass M., Reinthaller A., and Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 4 (2000) 159-172
19. Pötter R., Van Limbergen E., Gerstner N., and Wambersie A. Survey of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 58 (2001) 11-18
20. Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
21. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
22. Souhami L., Seymour R., Roman T.N., et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 27 (1993) 871-878
23. Strauss H.G., Kuhnt T., Laban C., et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 178 (2002) 378-385
24. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 17 (1999) 1339-1348